Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers
2024 · ESMO Real World Data and Digital Oncology · 2 citations
https://doi.org/10.1016/j.esmorw.2024.100075
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
264
Citations
4
h-index
3
i10-index
L. Roncoroni is an academic researcher. The author has contributed to research in topics: Celiac Disease Research and Management & Microscopic Colitis & Gastrointestinal disorders and treatments. The author has an h-index of 4, co-authored 43 publications.
https://doi.org/10.1016/j.esmorw.2024.100075
https://doi.org/10.1016/s1590-8658(24)00407-9
https://doi.org/10.1016/j.clnesp.2024.07.299
https://doi.org/10.1016/j.clnesp.2024.07.298
Click to start Chat